FDA Approves Emergency Use of Anti-Malarial Drugs to Treat People Infected with COVID-19
(Worthy News) – The US government is giving reserved approval to two new weapons in the war against the COVID-19 virus, which has so far claimed the lives of more than 2,500 in the US and a total of 35,300 people around the world.
The Food and Drug Administration (FDA) cut the red tape to give limited emergency-use approval to use the oral anti-malarial drugs chloroquine and hydroxychloroquine to treat patients infected with the novel coronavirus.
In a statement released Sunday night, the US Department of Health and Human Services announced it had received 30 million doses of hydroxychloroquine and one million doses of chloroquine donated to a national stockpile of potentially life-saving pharmaceuticals and medical supplies from the Swiss pharmaceutical giant Novartis. [ Source: CBN News (Read More…) ]
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌